2 monthes ago | By News Medical

The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers.
Read more ...

Researchers Are Studying Whether Paxlovid Can Treat Long COVID

2 monthes ago | By Time

Months after catching COVID-19 in December 2021, Lavanya Visvabharathy was still testing positive on antigen tests and suffering from symptoms including headaches and intense fatigue. So Visvabharathy, a research assistant professor of neurology at the Northwestern University Feinberg School of Medicine who has studied Long COVID since 2020, decided to conduct an experiment on herself.
She asked her doctor to prescribe her Paxlovid , an antiviral therapy that can treat COVID-19 by inhibiting replication of the virus that causes it. Paxlovid is meant to keep high-risk patients with acute...
Read more ...

Mass asymptomatic COVID-19 testing program reduced hospital admissions

2 monthes ago | By Healio

A voluntary mass testing program for individuals without COVID-19 symptoms was associated with a reduction in COVID-19-related hospital admissions, a study published in BMJ found.
Asymptomatic COVID-19 transmission has been a “major challenge” throughout the pandemic, Xingna Zhang, PhD, a research associate in the department of public health, policy and systems at the University of Liverpool, and colleagues noted.
“Modeling studies based on the original strain had suggested that more than half of transmissions in the community may arise from people without symptoms, whether
Read more ...